Suppr超能文献

胸部放疗与化疗对小细胞肺癌局部控制和生存的相互作用。

Interaction of thoracic irradiation and chemotherapy on local control and survival in small cell carcinoma of the lung.

作者信息

Cox J D, Byhardt R, Komaki R, Wilson J F, Libnoch J A, Hansen R

出版信息

Cancer Treat Rep. 1979 Aug;63(8):1251-5.

PMID:225027
Abstract

The records of all patients with small cell carcinoma of the lung seen in the Division of Therapeutic Radiology at The Medical College of Wisconsin from 1971 through 1977 were reviewed. Of 69 patients (34 with limited disease and 35 with extensive disease), 35 received irradiation only, nine received local plus total-body irradiation, and 25 received irradiation plus chemotherapy. In spite of the prompt response of the tumor, 16 of 35 patients who were only irradiated failed locally. Two patients who received local plus total-body irradiation failed in the chest. Only four of 25 irradiation plus chemotherapy patients failed locally in spite of much lower doses of thoracic irradiation. Limited-disease patients who had local control by irradiation had a slight increase (29 vs 22 weeks) in median survival. Patients receiving irradiation plus chemotherapy (three with limited and 22 with extensive disease) survived for a median of 56 weeks if the local tumor was controlled and for a median of 28 weeks if there was local failure. Regardless of therapy, survival beyond the median is greatly influenced by local tumor control.

摘要

回顾了1971年至1977年期间在威斯康星医学院放射治疗科就诊的所有肺小细胞癌患者的记录。69例患者(34例为局限性疾病,35例为广泛性疾病)中,35例仅接受了放疗,9例接受了局部加全身照射,25例接受了放疗加化疗。尽管肿瘤迅速反应,但仅接受放疗的35例患者中有16例局部失败。接受局部加全身照射的2例患者胸部出现失败。尽管胸部照射剂量低得多,但25例放疗加化疗患者中只有4例局部失败。通过放疗实现局部控制的局限性疾病患者的中位生存期略有增加(29周对22周)。如果局部肿瘤得到控制,接受放疗加化疗的患者(3例局限性疾病和22例广泛性疾病)的中位生存期为56周,如果出现局部失败则为28周。无论采用何种治疗方法,中位生存期之后的生存情况都受到局部肿瘤控制的极大影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验